The demand for anti-biofilm wound dressing in USA is projected to grow from USD 372.0 million in 2026 to USD 904.0 million by 2036, at a CAGR of 9.3%. Chemical will dominate with a 42.0% market share, while chronic wounds will lead the wound type segment with a 61.0% share.